User profiles for Izzet Altintas

Izzet Altintas

MD Ph.D student, Amager Hvidovre Hospital
Verified email at regionh.dk
Cited by 210

[HTML][HTML] Soluble urokinase receptor (SuPAR) in COVID-19–related AKI

…, S Pennathur, R Pop-Busui, I Altintas… - Journal of the …, 2020 - journals.lww.com
Background AKI commonly occurs in patients with coronavirus disease 2019 (COVID-19). Its
pathogenesis is poorly understood. The urokinase receptor system is a key regulator of the …

Soluble urokinase plasminogen activator receptor as a decision marker for early discharge of patients with COVID-19 symptoms in the emergency department

MA Stauning, I Altintas, T Kallemose… - The Journal of …, 2021 - Elsevier
Background Severe acute respiratory syndrome coronavirus 2 (The Covid-19 pandemic)
strains health care capacity. Better risk stratification, with discharge of patients with a predicted …

suPAR cut-offs for risk stratification in patients with symptoms of COVID-19

I Altintas, J Eugen-Olsen, S Seppälä… - Biomarker …, 2021 - journals.sagepub.com
Objectives: Elevated soluble urokinase Plasminogen Activator Receptor (suPAR) is a biomarker
associated with adverse outcomes. We aimed to investigate the associations between …

Biomarkers and the post-thrombotic syndrome: A systematic review of biomarkers associated with the occurrence of the post-thrombotic syndrome after lower extremity …

AN Harbsmeier, I Altintas, K Iversen… - …, 2023 - journals.sagepub.com
Introduction Post-thrombotic syndrome (PTS) is a frequent chronic complication of deep
venous thrombosis (DVT). Biomarkers are potentially valuable clinical tools for handling PTS. …

[HTML][HTML] Development and validation of prognostic machine learning models for short-and long-term mortality among acutely admitted patients based on blood tests

BN Jawad, SM Shaker, I Altintas, J Eugen-Olsen… - Scientific Reports, 2024 - nature.com
Several scores predicting mortality at the emergency department have been developed.
However, all with shortcomings either simple and applicable in a clinical setting, with poor …

Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19

…, EJ Giamarellos‐Bourboulis, I Altintas… - Journal of the …, 2022 - Am Heart Assoc
Background Venous thromboembolism (VTE) contributes significantly to COVID‐19 morbidity
and mortality. The urokinase receptor system is involved in the regulation of coagulation. …

Low levels of the prognostic biomarker suPAR are predictive of mild outcome in patients with symptoms of COVID-19-a prospective cohort study

J Eugen-Olsen, I Altintas, J Tingleff, M Stauning… - medRxiv, 2020 - medrxiv.org
OBJECTIVE To examine if baseline soluble urokinase plasminogen activator receptor (suPAR)
can predict whether patients with COVID-19 symptoms will need mechanical ventilation …

Development and validation of prognostic machine learning models for short-and long-term mortality among acutely hospitalized patients.

BJ Jawad, SM Shaker, I Altintas, J Eugen-Olsen… - 2023 - researchsquare.com
Background: Several scores predicting mortality at the emergency department have been
developed. However, all with shortcomings either simple and applicable in a clinical setting, …

Prospective and External Validation of Prognostic Machine Learning Models for Short-and Long-Term Mortality Among Acutely Admitted Patients Based on Blood …

BN Jawad, I Altintas, J Eugen-Olsen… - Available at SSRN …, 2024 - papers.ssrn.com
Background: The application of machine learning (ML) models in emergency departments (EDs)
to predict short-and long-term mortality encounters challenges, particularly in balancing …

Low levels of the prognostic biomarker suPAR are predictive of mild outcome in patients with symptoms of COVID-19-a prospective cohort study

I Altintas, J Tingleff, M Stauning, H Gamst-Jensen… - 2020 - pesquisa.bvsalud.org
OBJECTIVETo examine if baseline soluble urokinase plasminogen activator receptor (suPAR)
can predict whether patients with COVID-19 symptoms will need mechanical ventilation …